These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9561876)

  • 41. Myocardial viability in ischemic heart disease: new directions and perspectives.
    Previtali M
    Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
    Muellerleile K; Barmeyer A; Groth M; Lund GK
    Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MRI assessment of myocardial viability: comparison with other imaging techniques.
    Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
    Rays; 1999; 24(1):96-108. PubMed ID: 10358387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic role of dobutamine stress echocardiography in myocardial viability.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical applications of cardiac magnetic resonance imaging.
    Pilz G; Heer T; Harrer E; Ali E; Hoefling B
    Minerva Cardioangiol; 2009 Jun; 57(3):299-313. PubMed ID: 19513011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial viability testing in patients with severe left ventricular dysfunction by SPECT and PET.
    Demirkol MO
    Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():60-70. PubMed ID: 19028637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Toxic drug-induced myocardial diseases].
    Grötz J
    Dtsch Med Wochenschr; 1987 Apr; 112(17):691-5. PubMed ID: 3552551
    [No Abstract]   [Full Text] [Related]  

  • 49. Echocardiographic assessment of myocardial viability.
    Varga A; Cordovil A; Sicari R; Vassalle C; Picano E
    Rev Port Cardiol; 1995 Mar; 14(3):197-201. PubMed ID: 7766440
    [No Abstract]   [Full Text] [Related]  

  • 50. Myocardial viability: known and unknown.
    Bax JJ; Poldermans D; Rambaldi R; Valkema R; Slavich GA; Fioretti PM
    G Ital Cardiol; 1998 Mar; 28(3):229-36. PubMed ID: 9561876
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of myocardial viability in ischemic cardiomyopathy.
    Bax JJ
    Heart Lung Circ; 2005; 14 Suppl 2():S8-13. PubMed ID: 16352289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of myocardial viability in chronic ischemic heart disease: current status.
    Rizzello V; Poldermans D; Bax JJ
    Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rest-injected 201thallium in the evaluation of myocardial viability.
    Perrone-Filardi P; Dellegrottaglie S; Chiariello M
    Cardiologia; 1999 Jun; 44(6):515-20. PubMed ID: 10443052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myocardial hibernation: a noninvasive physician's point of view.
    Bonow RO
    Ital Heart J; 2002 May; 3(5):285-90. PubMed ID: 12066559
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.